Replies to post #277 on Idenix Pharmaceuticals (IDIX)

[DewDiligence]

A seldom mentioned distinction between Baraclude and Tyzeka:

The Baraclude FDA label has Pregnancy Category C while the Tyzeka FDA label has Pregnancy Category B.

Category B means that the drug is not teratogenic and has shown no adverse effects in developing embryos and fetuses in preclinical studies.